Trials / Completed
CompletedNCT03365622
Efficacy of IV Acetaminophen Versus Oral Acetaminophen
Randomized, Double-Blind Clinical Study Evaluating Efficacy of Intravenous Versus Enteric Acetaminophen in Donor Nephrectomy and Robot-Assisted, Laparoscopic Nephrectomy.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 214 (actual)
- Sponsor
- University of Rochester · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to determine whether intravenous acetaminophen compared to enteric acetaminophen offers increased efficacy in patients who are scheduled for laparoscopic donor nephrectomy and for patients scheduled for robot-assisted, laparoscopic nephrectomy for cancer at the University of Rochester Medical Center. The standard surgical and post-operative care, including post-operative pain management will not be altered.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | acetaminophen | Active Intravenous doses will consist of a single 1,000mg/100 ml IV dose with contents of commercial vials transferred to an empty sterile IV bag. |
| DRUG | Acetaminophen | 500mg acetaminophen tablet ,2 capsules oral every six hours for 24 hours |
| DRUG | Placebos | Placebo Intravenous doses will consist of 100ml of normal saline transferred to an empty sterile IV bag. |
| DRUG | Placebo Oral Tablet | Placebo, opaque capsules that have been filled with inert powder (lactose USP), 2 capsules oral every six hours for 24 hours |
Timeline
- Start date
- 2018-08-08
- Primary completion
- 2024-04-10
- Completion
- 2024-04-10
- First posted
- 2017-12-07
- Last updated
- 2025-06-29
- Results posted
- 2025-06-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03365622. Inclusion in this directory is not an endorsement.